Loading…
DarioHealth Corp. is projected to decline to $6.93 by 2027, a -4% move from its current price of $7.22. DRIO is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $6.97 | $7.22 | $7.48 | -0.02% |
| Jul 14 | $6.87 | $7.22 | $7.59 | -0.04% |
| Jul 15 | $6.79 | $7.22 | $7.67 | -0.06% |
| Jul 16 | $6.72 | $7.21 | $7.74 | -0.08% |
| Jul 17 | $6.66 | $7.21 | $7.81 | -0.10% |
| Jul 18 | $6.61 | $7.21 | $7.86 | -0.12% |
| Jul 19 | $6.57 | $7.21 | $7.92 | -0.14% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $6.57 | $7.21 | $7.92 | -0.14% |
| Week 2 | $6.31 | $7.20 | $8.22 | -0.29% |
| Week 3 | $6.11 | $7.19 | $8.45 | -0.43% |
| Week 4 | $5.95 | $7.18 | $8.65 | -0.58% |
| Week 5 | $5.82 | $7.17 | $8.83 | -0.72% |
| Week 6 | $5.69 | $7.16 | $9.00 | -0.87% |
| Week 7 | $5.58 | $7.15 | $9.15 | -1.01% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
DarioHealth Corp. operates as a digital health company in the United States and internationally. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a behavioral health offering that decreases the symptoms of stress, anxiety, and depression; Dario Move, focuses on improving posture to alleviate pain with medical device; and Dario Health, a self-care application and virtual coaching platform for diabetes, hypertension, and weight management and GLP-1. It also provides bundled full-suite or partial-suite subscriptions. The company was formerly known as LabStyle Innovations Corp.
and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
DRIO is a healthcare stock with a current price of $7.03 and a market capitalization of $51.41M. It is ranked 4534 in the market. The price outlook is captured in a long-range forecast that provides yearly min, avg, and max values along with ROI for each year from 2026 through 2050.
The forecast implies a path from neutral in the near term to bullish in the longer term, with substantial upside potential by 2050. The stock exhibits higher risk and volatility with an annualized volatility of 80% as part of its technical context.
A major floor 27.6% below — a decisive break under it would weaken the trend.
The nearest floor, 17.0% below — buyers have tended to step in here.
The nearest ceiling, 7.3% above — a clean break opens room to run.
A major ceiling 42.7% above — clearing it would confirm fresh momentum.
Key DRIO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of DRIO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $7.14 | Buy | $7.11 | Buy |
| MA 10 | $7.02 | Buy | $7.02 | Buy |
| MA 20 | $6.86 | Buy | $7.02 | Buy |
| MA 50 | $7.42 | Sell | $7.37 | Sell |
| MA 100 | $8.07 | Sell | $8.16 | Sell |
| MA 200 | $10.35 | Sell | $9.68 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 52.38 | Neutral |
| Stoch RSI (14) | 96.38 | Sell |
| CCI (20) | 70.68 | Neutral |
| Williams %R (14) | -4.65 | Info |
| MACD (12,26,9) | 0.09 | Buy |
| ROC (12) | 20.53 | Buy |
| Bollinger %B (20,2) | 0.72 | Neutral |
| Stochastic %K (14) | 95.35 | Sell |
| TRIX (15) | -0.37 | Sell |
| Awesome (5,34) | -0.02 | Sell |
| Ultimate (7,14,28) | 62.44 | Neutral |
| Momentum (10) | 1.07 | Buy |
| Aroon Osc (25) | -52.00 | Sell |
| Hull MA (9) | 7.20 | Buy |
| ADX (14) | 14.26 | Neutral |
| ATR (14) | 0.22 | Info |
The 30-day technical picture is bearish overall. RSI14 is 50. The 50-day simple moving average is $7.47 and the 200-day simple moving average is $10.35. Near-term support sits at $5.99 and resistance at $8.39.
The 30-day price range spans from $5.42 to $9.12, highlighting recent trading volatility. Annualized volatility is 80%, underscoring a wide swing in price over the period.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $5.99 | $7.22 | $9.15 | 0% | Neutral | |
| $5.36 | $6.93 | $9.55 | -4% | Neutral | |
| $5.10 | $6.84 | $9.87 | -5% | Neutral | |
| $6.11 | $8.45 | $12.63 | +17% | Neutral | |
| $6.88 | $9.78 | $15.07 | +35% | Bullish | |
| $6.55 | $9.55 | $15.10 | +32% | Bullish | |
| $6.36 | $9.49 | $15.36 | +32% | Bullish | |
| $5.92 | $9.05 | $14.96 | +25% | Bullish | |
| $6.17 | $9.63 | $16.22 | +33% | Bullish | |
| $7.19 | $11.46 | $19.65 | +59% | Bullish | |
| $7.60 | $13.33 | $24.59 | +85% | Bullish | |
| $12.28 | $25.58 | $52.47 | +254% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $5.99 | $7.22 | $8.84 | +0.00% |
| August 2026 | $6.18 | $7.35 | $9.02 | +1.79% |
| September 2026 | $5.90 | $7.08 | $8.82 | -3.60% |
| October 2026 | $5.91 | $7.15 | $9.01 | +0.98% |
| November 2026 | $6.05 | $7.37 | $9.37 | +2.97% |
| December 2026 | $5.82 | $7.13 | $9.15 | -3.21% |
Click any year to see its month-by-month DRIO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
DarioHealth Corp.'s 2026 outlook centres on $7.22, within a $5.99 to $9.15 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, DRIO could reach as high as $9.55, with a base case around $6.93 and support toward $5.36 — roughly -4% from $7.22. Price action looks broadly range-bound.
Expect DRIO to range from $5.10 to $9.87 through 2028. The $6.84 average target implies a -5% move from current prices. That is -1% versus the projected 2027 average. A consolidation phase looks the most probable path here.
The DRIO price prediction for 2029 points to an average of $8.45 (low $6.11, high $12.63) — a potential gain of +17% on today's $7.22. Price action looks broadly range-bound.
In 2030, DRIO is projected to trade between $6.88 and $15.07, averaging $9.78 — a potential gain of +35% from today's $7.22. That is up +16% on the projected 2029 average. Buyers look set to stay in control over this stretch.
DarioHealth Corp.'s 2031 outlook centres on $9.55, within a $6.55 to $15.10 range. That is -2% versus the projected 2030 average. That marks a +32% change versus current levels. Momentum favours further upside here.
By 2032, DRIO could reach as high as $15.36, with a base case around $9.49 and support toward $6.36 — roughly +32% from $7.22. Buyers look set to stay in control over this stretch.
Expect DRIO to range from $5.92 to $14.96 through 2033. The $9.05 average target implies a +25% move from current prices. That is -5% versus the projected 2032 average. Momentum favours further upside here.
The DRIO price prediction for 2034 points to an average of $9.63 (low $6.17, high $16.22) — a potential gain of +33% on today's $7.22. Buyers look set to stay in control over this stretch.
In 2035, DRIO is projected to trade between $7.19 and $19.65, averaging $11.46 — a potential gain of +59% from today's $7.22. That is up +19% on the projected 2034 average. Momentum favours further upside here.
DarioHealth Corp.'s 2040 outlook centres on $13.33, within a $7.60 to $24.59 range. That is up +16% on the projected 2035 average. That marks a +85% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, DRIO could reach as high as $52.47, with a base case around $25.58 and support toward $12.28 — roughly +254% from $7.22. Momentum favours further upside here.
Investing $1,000 in DRIO today (≈ 138.504155 DRIO) could be worth
$3,543.36
+$2,543.36 (+254%) by 2050 · US Dollar
Based on the average projected DRIO price of $25.58 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in DRIOwould be worth at today's price.
$1,000 invested in DRIO on Jul 10, 2025 (≈ 69.735006 DRIO) would be worth
$503.49
-$496.51 (-49.7%) today · 0.50× · US Dollar
Based on a DRIO entry price of $14.34 vs. today's $7.22.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $7.28 | $991.76 | -0.8% |
| 1 month ago | $7.21 | $1,001.39 | +0.1% |
| 3 months ago | $7.25 | $995.86 | -0.4% |
| 6 months ago | $11.67 | $618.68 | -38.1% |
| 1 year ago | $14.34 | $503.49 | -49.7% |
| All time (5.0y) ago | $387.6 | $18.63 | -98.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our DRIO forecast.
Our base-case forecast reaches $14.00 around 2050.
Implied market cap at $14.00: $102.37M
The multi-year forecast moves from neutral in the near term to bullish in the longer term. For 2026 the expected average price is $7.03 with a min of $5.99 and a max of $8.71 (ROI 0%), and 2027 shows a min of $5.06, avg $6.64, max $9.35 (ROI -5.6%). 2028 projects a min of $4.69, avg $6.43, max $9.51 (ROI -8.6%).
2029 turns positive with a min of $5.48, avg $7.78, max $11.96 (ROI 10.7%). Beginning in 2030 the forecast is bullish, with min $6.45, avg $9.45, max $15.00 (ROI 34.4%). The bullish trend continues through 2031–2034 with 2031 avg $8.94 (ROI 27.2%), 2032 avg $8.66 (ROI 23.1%), 2033 avg $8.59 (ROI 22.2%), and 2034 avg $8.71 (ROI 23.8%).
In 2035 the avg is $10.22 (ROI 45.4%), and by 2040 the avg climbs to $11.94 (ROI 69.8%). By 2050 the forecasted avg is $22.51 with a max of $48.58 (ROI 220.3%). These figures reflect estimates and are not guarantees, and they illustrate potential paths under varying conditions and uncertainties.
Tap a question to reveal the answer.
2030 average price is $9.45, with a min of $6.45 and a max of $15.00; ROI 34.4%. These are estimates, not guarantees.
The forecast shows neutral sentiment in 2026, 2027, and 2028 with average prices in the $6–$7 region, a positive shift in 2029, and bullish momentum from 2030 onward, with 2030 average $9.45 and 2050 average $22.51 (ROI up to 220.3%). These are estimates and carry risk.
Yes. The forecast for 2035 shows an average price of $10.22 and a max of $18.20 (ROI 45.4%). There is no guarantee, and outcomes depend on market conditions.
The 30-day range is $5.42 to $9.12. RSI14 is 50, with SMA50 at $7.47 and SMA200 at $10.35. Support is at $5.99 and resistance at $8.39, reflecting a bearish near-term tone amidst established levels.
Current price is $7.03 and market cap is $51.41M. The rank is 4534.
DarioHealth Corp. Community Discussion
0Share your DarioHealth Corp. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.